A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
Stopped early · Early Phase 1
Conditions studied: Alzheimers Disease, AD
In brief
\[F-18\]T807 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.
Key facts
- Study ID
- NCT01733355
- Run by
- Avid Radiopharmaceuticals
- People needed
- 11
- Starts
- 2012-07-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2013-07-19
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Irvine, California, United States
- Research Site — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.